Last reviewed · How we verify
NCT06886711
Research on the Role of Probiotics in Human Intestinal Health
NA trial testing Probiotic in Intestinal Microbiota in 45 participants. Not yet recruiting.
30 September 2025
Quick facts
| Lead sponsor | Wecare Probiotics Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 10 March 2025 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Probiotic
- Placebo
Conditions studied
- Intestinal Microbiota — all drugs for Intestinal Microbiota →
Sponsor
Wecare Probiotics Co., Ltd. — full company profile →
Who can join
Adults 18 to 45, any sex, with Intestinal Microbiota. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluate the efectiveness and safety of Bifidobacterium bifidum BBi32 as a food supplement compared to a placebo in improving intestinal andimmune functions in healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Safety and Tolerability of <i>Bifidobacterium bifidum</i> BBi32: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial With Genomic and In Vitro Corroboration.
Fang S, Wang S, Liu Y, Zhu C, et al · · 2026 · PMID 41523287 · DOI 10.1002/fsn3.71420
Verify or expand the search:
- PubMed search for NCT06886711
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Probiotic
Trials testing the same drug.
- NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
- NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
- NCT07462481 — Probiotic Improve Constipation · NA · recruiting
- NCT07511855 — Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term T · Phase 2 · not yet recruiting
- NCT07474064 — Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC · Phase 2 · not yet recruiting
Other recruiting trials for Intestinal Microbiota
Currently open trials in the same condition.
- NCT05003505 — Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection · active not recruiting
Other Wecare Probiotics Co., Ltd. trials
Trials by the same sponsor.
- NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
- NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
- NCT07462494 — Probiotic Intervention in Constipation · NA · not yet recruiting
- NCT07462481 — Probiotic Improve Constipation · NA · recruiting
- NCT07507929 — Probiotic for Weight Management in Overweight and Obese Adults · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06886711 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wecare Probiotics Co., Ltd.
- Last refreshed: 20 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06886711.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing